RB

Robert Barnes

Mr Barnes is an executive who has delivered leadership and operational outcomes across a variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics. Having worked globally and in Australia in healthcare organizations, he brings diverse commercial and scientific understanding to the Company. Robert has held senior executive roles at several pharmaceutical and consumer healthcare entities including Aspen Pharmacare Australia Pty Ltd, Sanofi Australia, and Mayne Group. He has experience in the medicinal cannabis sector, being a former member of the advisory board to Leafcann Group Pty Ltd. He is Chair of the Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
02/12/240266,667300,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
02/12/24
Issued
66,667$0.040$2,666Rights issue
15/11/24
Issued
300,000$0.045$13,500Issue of securities
05/06/24
Buy
200,000$0.050$10,000On-market trade